Carl Zeiss MicroImaging (Thornwood, NY) has launched a new technology that delivers high content analyses to research microscopes. The ASSAYbuilder is a suite of next-generation high content analyses (HCA) tools that can be added to any microscope with a digital imaging package including AxioVision. For the first time, any researcher can upgrade their ZEISS microscope to an HCA system at a fraction of the price of existing high content screening systems.
High content screening has accelerated drug discovery in the pharmaceutical industry for years. Leveraging the power of research microscopy for high content analyses promises to enable precise assay development and hit qualification for the screening community, while reducing the access cost for academics that need greater flexibility when imaging and analyzing biological targets.
Carl Zeiss Microimaging